432 filings
Page 2 of 22
S-8 POS
g0v99g0p9g1diwxn
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:34am
S-8 POS
vz9enbr6yyrjj4t
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:33am
S-8 POS
iw3his
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:32am
S-8 POS
uyruumxvxc0z4867t
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:29am
S-8 POS
6vh73b2b bh7
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:27am
S-8 POS
xoqtfu8 p9r34d1
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:20am
8-K
jtnh x7f6ze2nsjg55
22 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
166d5
15 Mar 23
Entry into a Material Definitive Agreement
6:05am
8-K
mttsenrbttqti2u
13 Mar 23
Other Events
8:00am
8-K
b4cchh
3 Feb 23
Cost Associated with Exit or Disposal Activities
6:02am
8-K
ltbfe3zooq 2zfj
5 Jan 23
Entry into a Material Definitive Agreement
9:26am
8-K
xrxtfp26clj4
4 Jan 23
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
4:13pm
8-K
3i76kx9
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
ioiraduees
5 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
5z3ryh
16 Nov 22
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
5:26pm
8-K
55xp05xox0h5box
16 Nov 22
Other Events
4:59pm
8-K
5zo0jipo5a1gyyvscftl
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
8-K
baqw119o0n
2 Nov 22
Material Modifications to Rights of Security Holders
8:00am